Prescription drug · NDA
Arbli (Losartan potassium) NDC 83245-053
Losartan potassium 10 mg/mL · Suspension · Oral · Scienture LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 83245-053-06 | 8324500530683245005306 | 1 BOTTLE in 1 CARTON (83245-053-06) / 165 mL in 1 BOTTLEMarketed from Mar 19, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Arbli
- Generic name (nonproprietary)
- losartan potassium
- Active ingredients
- Losartan potassium — 10 mg/mL
- Dosage form
- Suspension
- Route
- Oral
- Labeler
- Scienture LLCNDC labeler code 83245
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 218772
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin 2 Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 83245-053_0d6183d3-e8e3-416e-a359-9348c61ac736SPL ID 0d6183d3-e8e3-416e-a359-9348c61ac736SPL set ID afd2d1ba-e7af-4e4e-8b7e-a9f72612fc97RxCUI 2709039, 2709046UNII 3ST302B24AUPC 0383245053063
- Pharmacologic class
- Angiotensin 2 Receptor Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N483245005306followed by a unit qualifier and the quantityPackage 83245-0053-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Arbli is an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy. There is evidence that this benefit does not apply to Black patients. ( 1.2 ) Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria in patients with type 2 diabetes and a history of hypertension. ( 1.3 ) 1.1 Hypertension Arbli is indicated for the treatment of hyperten…
Excerpt only. Read the full label for complete information.
About NDC 83245-053
- What is NDC 83245-053?
- 83245-053 is the product NDC for Arbli (losartan potassium), Losartan potassium 10 mg/mL suspension, listed with the FDA by Scienture LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Arbli (Losartan potassium).
- What is the active ingredient?
- Losartan potassium.
- Who is the labeler?
- Scienture LLC, NDC labeler code 83245. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Arbli?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.